Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study)

Intensive Care Medicine

Volumn 22, Issue 10, 1996, Pages 1057-1065

  Jarlier, V ^a   Fosse, T ^b   Philippon, A ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b PASTEUR HOSPITAL   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

Antibiotic susceptibility; Intensive care unit

Indexed keywords

AMINOGLYCOSIDE; AZTREONAM; BETA LACTAM; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; PIPERACILLIN; QUINOLONE DERIVATIVE; TOBRAMYCIN;

ACINETOBACTER; AEROBIC BACTERIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; BLOOD; ESCHERICHIA COLI; FRANCE; GRAM NEGATIVE BACTERIUM; HUMAN; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM; SPECIES DIFFERENCE; URINARY TRACT;

EID: 0029806374     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01699228     Document Type: Article

References (39)

1. Weinstein MP, Reller LB, Murphy JR, Lichtenstein A (1983) The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Clin Infect Dis 5:35-53
2. Geerdes HF, Ziegler D, Lode H, Hund M, Loehr A, Fangmann W, Wagner J (1992) Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989. Clin Infect Dis 15:991-1002
3. Rouby JJ, Rossignon MD, Nicolas MH, Martin de Lassale MM, Cristin S, Grosset J, Viars P (1989) A prospective study of protected bronchoalveolar lavage in diagnosis of nosocomial pneumonia. Anesthesiology 71:679-685
4. Schaberg DR, Culver DH, Gaynes RP (1991) Major trends in the microbial etiology of nosocomial infection. Am J Med 38:72S-75S
5. Craven DE, Steger KA, Barber TW (1991) Preventing nosocomial pneumonia: state of the art and perspectives for the 1990s. Am J Med 91:44S-53S
6. Kreger BE, Craven DE, Carling PC, McCabe WR (1980) Gram negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med 68:332-343
7. McGowan AP, Brown NM, Holt HA, Levering AM, McCulloch SY, Reeves DS (1993) An eight-year survey of the antimicrobial susceptibility patterns of 85971 bacteria isolated from patients in a district general hospital and the local community. J Antimicrob Chemother 31:543-557
8. McGowan JE, Barnes MW, Finland M (1975) Bacteremia at Boston City Hospital: occurrence and mortality during 12 selected years (1935-1972), with special reference to hospital acquired cases. J Infect Dis 132:316-335
9. Buirma RJA, Horrevorts AM, Wagenwoort JHT and Participants in the 1990 Dutch Surveillance Study (1991) Incidence of multi-resistant gram-negative isolates in eight Dutch hospitals. Scand J Infect Dis Suppl 78:35-44
10. Shah PM, Asanger R, Kahan FM (1991) Incidence of multiresistance in gram-negative aerobes from intensive care units of 10 German hospitals. Scand J Infect Dis Suppl 78:22-34
11. Snydman DR (1991) Clinical implications of multi-drug resistance in the intensive care unit. Scand J Infect Dis Suppl 78: 54-63
12. Verbist L (1991) Incidence of multi-resistance in gram-negative bacterial isolates from intensive care units in Belgium: a surveillance study. Scand J Infect Dis Suppl 78:45-53
13. Balows A (ed) (1991) Manual of clinical microbiology, 5th edn. American Society for Microbiology, Washington DC
14. National Committee for Clinical Laboratory Standards (1990) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A2. NCCLS, Villanova, PA
15. Philippon A, Labia R, Jacoby G (1989) Extended-spectrum β-lactamases. Antimicrob Agents Chemother 33:1131-1136
16. Sanders WE, Sanders WE Jr (1983) Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future. Clin Infect Dis 5:639-648
17. Sanders CC, Sanders E Jr (1986) Type I β-lactamases of gram-negative bacteria: interactions with β-lactam antibiotics. J Infect Dis 154:792-800
18. Joly-Guillou ML, Bergogne-Berezin E, Philippon A (1988) Distribution of β-lactamases and phenotype analysis in clinical strains of Acinetobacter calcoaceticus. J Antimicrob Chemother 22:597-604
19. Philippon A, Leclerc P, Jarlier V (1991) Multicenter survey on β-lactam susceptibility of gram negative bacteria. Proceedings of the 17th international congress of chemotherapy, session 29, pp 372-373
20. Trias J, Dufresne J, Levesque JRC, Nikaido H (1989) Decreased outer membrane permeability in imipenem-resistant mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother 33: 1201-1206
21. Sirot DL, Goldstein FW, Soussy CJ, Courtieu AL, Husson MO, Lemozy J, Meyran M, Morel C, Perez R, Quentin-Noury C, Reverdy ME, Scheftel JM, Rosenbaum M, Rezvani Y (1992) Resistance to cefotaxime and seven other β-lactams in members of the family Enterobacteriaceae: a 3-year survey in France. Antimicrob Agents Chemother 36: 1677-1681
22. Goldstein FW, Pean Y, Gertner J, Gutmann L and the Vigil'Roc Study Group (1993) Characterization of ceftriaxone-resistant Enterobacteriaceae: a multicentre study in 26 French hospitals. J Antimicrob Chemother 32:595-603
23. Jarlier V, Bismuth R, Nicolas MH, Nguyen J, Truffot C, Grosset J (1984) Survey of the phenotype of susceptibility to beta-lactams in Enterobacteriaceae at the Pitie-Salpetriere Hospital. J Antimicrob Chemother 14 [Suppl B]: 59-65
24. Soussy C, Duval J, Courvalin P (1988) Résistance aux antibiotiques chez Escherichia coli: états actuels et nouvelles acquisitions. Méd Mal Inf 7:29-36
25. Thabaut A, Acar J, Allouch P, Arlet G, Berardi-Grassias L, Bergogne-Bérézin E, Brun Y, Buisson Y, Chabanon G, Cluzel R, Courtieu A, Dabernat H, Duval J, Fleurett J, Jarlier V, Meyran M, Monteil H, Nevot P, Petithory JC, Philippon A, Reverdy ME, Reynaud A, Sedallian A, Sirot J, Werneburg B (1990) Frequency and distribution of betalactamases in Klebsiella pneumoniae in France between 1985 and 1988. Pathol Biol 38:459-463
26. Sirot D, Sirot J, Labia R, Morand A, Courvalin P, Darfeuille-Michaud A, Perroux R, Cluzel R (1987) Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamase. J Antimicrob Chemother 20: 323-334
27. Sirot J, Chanal C, Petit A, Sirot D, Labia R, Gerbaud G (1988) Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated β-lactamases markedly active against third-generation cephalosporins: epidemiologic studies. Clin Infect Dis 10:850-859
28. Philippon A, Ben Redjeb S, Fournier G, Ben Hassen A (1989) Epidemiology of extended spectrum β-lactamases. Infection 17:347-354
29. Jarlier V, Nicolas MH, Fournier G, Philippon A (1988) Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Clin Infect Dis 10: 867-878
30. Brun-Buisson C, Philippon A, Ansquer AM, Legrand P, Montravers F, Duval J (1987) Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet II: 302-306
31. McGowan J Jr, Hall EC, Parrott PL (1989) Antimicrobial susceptibility in gram-negative bacteremia: are nosocomial isolates really more resistant? Antimicrob Agents Chemother 33:1855-1859
32. Milatovic D, Braveny I (1987) Development of resistance during antibiotic therapy. Eur J Clin Microbiol Infect Dis 6:234-244
33. Sugarman B, Pesanti E (1980) Treatment failures secondary to in vivo development of drug resistance by microorganisms. Clin Infect Dis 2:153-167
34. Medeiros AA, Kent RL, O'Brien TF (1974) Characterization and prevalence of the different mechanisms of resistance to beta-lactam antibiotics in clinical isolates of Escherichia coli. Antimicrob Agents Chemother 6:791-801
35. Bure A, Legrand P, Arlet G, Jarlier V, Paul G, Philippon A (1988) Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam. Eur J Clin Microbiol Infect Dis 7:780-782
36. Pangon B, Bizet C, Bure A, Pichon F, Philippon A, Regnier B, Gutmann L (1989) In vivo selection of a cephamycin-resistant porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 β-lactamase. J Infect Dis 159:1005-1006
37. Dib C, Trias J, Jarlier V (1995) Lack of additive effect between mechanism of resistance to carbapenems and other beta-lactam agents in Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis 14: 979-986
38. Cambau E, Perani E, Dib C, Petinon C, Trias J, Jarlier V (1995) Rôle of mutations in DNA gyrase genes in ciprofloxacin resistance of Pseudomonas aeruginosa susceptible or resistant to imipenem. Antimicrob Agents Chemother 39:2248-2252
39. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoine MH, Wolff M, Spencer RC, Hemmer M (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA 274: 639-644